Patterson, Marilyn
Beausang, Lee Anne
Rup, Bonita
Bowsher, Ronald R.
Krug, Kim
Melhem, Murad
Lu, Sharon
Article History
Received: 9 August 2021
Accepted: 17 November 2021
First Online: 20 December 2021
Declarations
:
: The human biological samples were sourced ethically, and their research use was in accordance with the terms of the informed consents under an IRB/IEC approved protocol.
: All authors consent to publication of this manuscript.
: Marilyn Patterson has nothing to disclose.Lee Anne Beausang has nothing to disclose.Bonita Rup reports consulting with Tesaro/GlaxoSmithKline on the work described in this manuscript; no compensation was received for the preparation of this manuscript.Ronald R. Bowsher reports support contracted by Tesaro/GlaxoSmithKline to conduct statistical data analysis for determination of immunogenicity cut points.Kim Krug reports support contracted by Tesaro/GlaxoSmithKline to conduct statistical data analysis for determination of immunogenicity cut points.Murad Melhem is an employee of GlaxoSmithKline.Sharon Lu is a former employee of GlaxoSmithKline.